Skip to main content
NIH funding notice PA-18-004

Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional)

Closed on January 7, 2020.

Posted
November 3, 2017
Close date
January 7, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,383,087 in first-year total cost, median $454,308.

Most frequent study sections

  1. Clinical Management of Patients in Community-based Settings Study Section[CMPC]2
  2. Dissemination and Implementation Research in Health Study Section[DIRH]1
  3. Health Disparities and Equity Promotion Study Section[HDEP]1
  4. Psychosocial Risk and Disease Prevention Study Section[PRDP]1

Most frequent institutions

  1. DUKE UNIVERSITY1
  2. EMORY UNIVERSITY1
  3. THOMAS JEFFERSON UNIVERSITY1
  4. UNIV OF NORTH CAROLINA CHAPEL HILL1
  5. UNIVERSITY OF TX MD ANDERSON CAN CTR1
Competing awards under PA-18-004 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Optimizing Endocrine Therapy Adherence through Motivational Interviewing and Text Interventions1R01CA237357-01REEDER-HAYES, KATHERINE EWHEELER, STEPHANIE BROOKEUNIV OF NORTH CAROLINA CHAPEL HILL, NC$636,094CMPC
2019A Mobile TXT-based Intervention to Improve Adherence to Adjuvant Hormone Therapy and Symptom Management for BCa Survivors1R01CA222246-01A1WEN, KUANG-YITHOMAS JEFFERSON UNIVERSITY, PA$505,332PRDP
2019Oral Chemotherapy Adherence Trajectories in Chronic Myeloid Leukemia1R01CA236871-01YEAGER, KATHERINE AYLWARDEMORY UNIVERSITY, GA$454,308CMPC
2019Targeted Oral Anticancer Agents: Patterns of Indicated and Off-Label Use, the Associated Factors, and Economic Implications1R01CA225647-01A1SHIH, YA-CHEN TINAUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$407,421DIRH
2019Disparities in the Use of Oral Anticancer Agents in Kidney Cancer1R01CA226842-01A1DINAN, MICHAELA ANNDUKE UNIVERSITY, NC$379,932HDEP

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PA-18-004: Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) | ScienceDex | ConductScience